Replies to post #101 on Filana Therapeutics Inc (FLNA)

[dr_lowenstein]

It is possible that no other product will ever be able to match OxyContin’s abuse-resistant designation.

Yes it is true, and if so could be a crushing blow for all the companies in this space such as PTIE, ACUR and of course ELTP.